Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswireApr 24 08:00 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Collegium Pharmaceutical Down Nearly 7%, on Track for Lowest Close Since November 2023 -- Data Talk

Dow JonesApr 10 15:42 ET

Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsApr 10 03:31 ET · Ratings

These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Extensively

Simply Wall StApr 7 15:14 ET

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

GlobeNewswireApr 1 08:00 ET